March 21, 2011 14:59 ET

Global Point of Care Market Reached $7.7 Billion in 2010

NEW YORK, NY--(Marketwire - March 21, 2011) - cites in its newly published "Point of Care Diagnostic Testing World Markets" report that the global point of care market reached $7.7 billion in 2010 and is growing at 7% per year. For more information, visit:

Point of care testing (POCT) covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening. During 2010, 950 million point of care tests were carried out within hospitals in the U.S. This is expected to grow to 1.5 billion tests annually by 2012.

The "Point of Care Diagnostic Testing World Markets" report covers:

  • Blood Glucose Testing
  • Blood Gas and Electrolytes Analysis
  • Rapid Coagulation Testing
  • Rapid Cardiac Markers Diagnostics
  • Drugs of Abuse Screening
  • Urine Strips Testing
  • Pregnancy Testing
  • Fecal Occult Blood Testing
  • Food Pathogens Screening
  • Hemoglobin Diagnostics
  • Infectious Disease Testing
  • Cholesterol Screening

The "Point of Care Diagnostic Testing World Markets" report examines companies manufacturing point of care equipment and supplies in the world. Companies covered include:

3M, Abaxis, Abbott, Accumetrics, AccuTech, ACON, Acrongenomics, Aerscher, Akers Biosciences, Alere, Alfa Scientific, American Bio Medica, Amic, Ani Biotech Oy, Arkray, Atonomics, Augurix, Axis-Shield, Bayer, Beckman Coulter, Becton Dickinson (BD), BioLytical, Biomerica, BiOracle, Bio-Rad, BioScan, BioSite, Calmark, Calypte, Chembio, Chempaq, Cholestech, Claros, Concateno, Dexcom, Enigma Diagnostics, Epinex, Eurotrol, Exalenz, GenBio, Genzyme, Helena, HemoCue, HemoSense, IND Diagnostic, Inverness, i-stat, Jant Pharmacal, Johnson & Johnson, Lein Applied Diagnostics, LifeAssays, LifeScan, LifeSign, MediSense, Mediwatch, Medix Biochemica, MedMira, MELA Sciences, Meretek, Meridian Bioscience, Micronics, New Horizons, Nova Biomedical, OraSure, Orion Diagnostica, Prima Biomedical, Qualigen, Quidel, Radiometer, Response Biomedical, Roche, Siemens Healthcare, Stanbio and TheraSense.

Detailed charts with sales forecasts and marketshare data are included. For more information, visit:

About is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.

Contact Information